BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 20662661)

  • 1. Bilateral panuveitis following intravesical BCG immunotherapy for bladder carcinoma.
    Uppal GS; Shah AN; Tossounis CM; Tappin MJ
    Ocul Immunol Inflamm; 2010 Aug; 18(4):292-6. PubMed ID: 20662661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Unilateral panuveitis following intravesical therapy with bacille of Calmette et Guerin].
    Loukil I; Ammari L; Hachicha F
    Bull Soc Belge Ophtalmol; 2012; (320):23-8. PubMed ID: 22978181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Calmette-Guerin bacillus disseminated infection after intravesical instillation].
    Borré S; Brustia D; Rosa F; Brondolo R; Rizzo G; Garavelli PL
    Recenti Prog Med; 2002 Apr; 93(4):247-8. PubMed ID: 11989131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prophylactic effect of inductive intravesical instillation of Bacillus Calmette-Guerin on postoperative recurrence of bladder cancer].
    Yi SH; Ye G; Wang XW; Jin HS; Zhang YN; Yan ZL
    Ai Zheng; 2008 Nov; 27(11):1208-11. PubMed ID: 19000455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Reiter syndrome after intravesical Bacillus Calmette-Guerin (BCG) immunotherapy: a case report].
    Shiba M; Fujii T; Takatera H
    Hinyokika Kiyo; 2003 Oct; 49(10):599-601. PubMed ID: 14655604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group Study.
    Lamm DL; Blumenstein BA; Crissman JD; Montie JE; Gottesman JE; Lowe BA; Sarosdy MF; Bohl RD; Grossman HB; Beck TM; Leimert JT; Crawford ED
    J Urol; 2000 Apr; 163(4):1124-9. PubMed ID: 10737480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eosinophilic cystitis induced by bacillus Calmette-Guerin (BCG) intravesical instillation.
    Hidoussi A; Slama A; Jaidane M; Zakhama W; Youssef A; Ben Sorba N; Mosbah AF
    Urology; 2007 Sep; 70(3):591.e9-10. PubMed ID: 17905131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tuberculous epididymo-orchitis following intravesical BCG for superficial bladder cancer.
    Bulbul MA; Hijaz A; Beaini M; Araj GF; Tawil A
    J Med Liban; 2002; 50(1-2):67-9. PubMed ID: 12841318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Two cases of successful treatments with steroid for local and systemic hypersensitivity reaction following intravesical instillation of Bacillus Calmette-Guerin].
    Shimasaki N; Yamasaki I; Kamada M; Syuin T
    Hinyokika Kiyo; 2001 Apr; 47(4):281-4. PubMed ID: 11411106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of intravesical chemotherapy versus BCG immunotherapy on recurrence of superficial transitional cell carcinoma of the bladder: metaanalytic reevaluation.
    Huncharek M; Kupelnick B
    Am J Clin Oncol; 2003 Aug; 26(4):402-7. PubMed ID: 12902895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spectrum of bacille Calmette-Guérin (BCG) infection after intravesical BCG immunotherapy.
    Gonzalez OY; Musher DM; Brar I; Furgeson S; Boktour MR; Septimus EJ; Hamill RJ; Graviss EA
    Clin Infect Dis; 2003 Jan; 36(2):140-8. PubMed ID: 12522745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoprophylactic intravesical application of bacillus Calmette-Guerin after transurethral resection of superficial bladder cancer.
    Librenjak D; Situm M; Eterovic D; Dogas Z; Gotovac J
    Croat Med J; 2003 Apr; 44(2):187-92. PubMed ID: 12698510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uveitis in a patient treated with Bacille-Calmette-Guérin: possible antigenic mimicry of mycobacterial and retinal antigens.
    Garip A; Diedrichs-Möhring M; Thurau SR; Deeg CA; Wildner G
    Ophthalmology; 2009 Dec; 116(12):2457-62.e1-2. PubMed ID: 19815288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical investigation on the effect of intravesical instillation of antifibrinolytic agents with bacillus Calmette-Guerin on preventing bladder cancer recurrence].
    Ding GQ; Shen ZJ; Lu J; Jin XD; Chen J; Shi SF
    Zhonghua Wai Ke Za Zhi; 2005 Nov; 43(22):1457-60. PubMed ID: 16318813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bladder contracture: review for intravesical bacillus Calmette-Guerin complication.
    Hameed A; Sezian N; Thwaini A
    Can J Urol; 2007 Dec; 14(6):3745-9. PubMed ID: 18163926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitiligo--an autoimmune side-effect of intravesical bacillus Calmette-Guérin instillation?
    Beisland C; Holsen DS
    Scand J Urol Nephrol; 2004; 38(2):182-3. PubMed ID: 15204415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary Interleukin-8 and 18 predict the response of superficial bladder cancer to intravesical therapy with bacillus Calmette-Guerin.
    Thalmann GN; Sermier A; Rentsch C; Möhrle K; Cecchini MG; Studer UE
    J Urol; 2000 Dec; 164(6):2129-33. PubMed ID: 11061941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BCG pyelonephritis following intravesical therapy for transitional cell carcinoma.
    Garcia JE; Thiel DD; Broderick GA
    Can J Urol; 2007 Apr; 14(2):3523-5. PubMed ID: 17466161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Panuveitis following intravesical bacille Calmette-Guerin therapy].
    Jacob M; Gambrelle J; Fleury J; Durieu I; Kodjikian L; Duquesne N; Grange JD
    J Fr Ophtalmol; 2006 May; 29(5):552-5. PubMed ID: 16885830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haemophagocytic syndrome after intravesical bacille Calmette-Guérin instillation.
    Misra S; Gupta A; Symes A; Duncan J
    Scand J Urol; 2014 Jun; 48(3):328-30. PubMed ID: 24070063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.